scPharmaceuticals Inc. (SCPH) Stock

SCPH logo

scPharmaceuticals Inc.

SCPH
Healthcare

Company profile

scPharmaceuticals reported revenue of $36.33 million for fiscal year 2024, up 167.3% from fiscal year 2023. In Q2 2025 (the quarter ended June 30, 2025) revenue was $16.04 million, up 99.2% from a year before. In Q2 2025 it reported a net loss of $18.02 million, against a net loss of $17.09 million a year earlier.

What stands out

  • It reported a net loss in each of its last 5 fiscal years; the loss widened from $54.81 million in fiscal year 2023 to $85.15 million in fiscal year 2024.
  • Its average diluted share count rose 15.6% in fiscal year 2024, from 38.5 million to 44.5 million shares.
  • Revenue in fiscal year 2024 was the highest of the last 5 fiscal years.

Figures from company filings; latest fiscal year ended December 31, 2024.

How much revenue does scPharmaceuticals make?

scPharmaceuticals reported $36.33 million in revenue for fiscal year 2024, up 167.3% from $13.59 million in fiscal year 2023. In Q2 2025 revenue was $16.04 million.

What companies are similar to scPharmaceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include PT Kalbe Farma Tbk. (KLBF.JK), Alteogen Inc. (196170.KQ), Chugai Pharmaceutical Co., Ltd. (4519.T), DHG Pharmaceutical Joint Stock Company (DHG.VN).

Has scPharmaceuticals made a profit in recent years?

Net income by fiscal year: FY2020, a loss of $32.21 million; FY2021, a loss of $28.03 million; FY2022, a loss of $36.84 million; FY2023, a loss of $54.81 million; FY2024, a loss of $85.15 million. It reported a net loss in each of these 5 years.

How has scPharmaceuticals' revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2020, $0; FY2021, $0; FY2022, $0; FY2023, $13.59 million; FY2024, $36.33 million.

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
Founded2014
IPO DateNov 17, 2017
IPO StatusPublic
FoundersPieter Muntendam
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “scPharmaceuticals Inc. (SCPH)”, data as of Jun 30, 2025, https://dataporium.tech/stocks/SCPH

LinkedInLinkedInXXYouTubeYouTube